Miami
Counsels clients on initial and follow-on public offerings, and SPAC, at-the-market, and off-the-shelf offerings
Advises on registered direct and PIPE financings, private placements, bridge financings, equity lines, and related transactions
Handles mergers and acquisitions, joint ventures, and licensing and distribution arrangements
Advises life sciences clients, including pharmaceutical and medical device companies, on financings and M&A
Robert (Bob) H. Cohen focuses his practice on transactional and securities work for a broad range of clients. He counsels clients on initial and follow-on public offerings; special-purpose acquisition (SPAC), at-the-market (ATM) and off-the-shelf offerings; registered direct and private investment in public equity (PIPE) financings; private placements; bridge financings and equity lines; and related transactions. Bob also has extensive experience in mergers and acquisitions, joint ventures, 1933 and 1934 Act representation, and licensing and distribution arrangements.
Bob has deep, industry-specific knowledge across numerous markets, particularly in the life sciences industry, where he has handled financings and mergers and acquisitions for pharmaceutical and medical device companies.
He is a contributor to The Life Science Executive’s Fundraising Manifesto, published by Life Science Nation, which provides scientists with the fundamentals needed to brand their companies.
Ranked in
Legal 500 US, Recommended
Ranked in
LMG Life Sciences, Life Sciences Star
Ranked in
Super Lawyers
- Legal 500 US, Recommended, 2023-2025
- LMG Life Sciences, Life Sciences Star, 2016
- Super Lawyers, 2007-2012
- New York University, MBA
- New York University School of Law, JD
- University at Albany, BA
- Florida
- New York
- US District Court for the Eastern District of New York
- US District Court for the Southern District of New York
- English
